Form 4: Neuronetics Director Glenn Muir Awarded 30,000 Restricted Stock Units

Neuronetics, Inc. Director Glenn Muir has been granted 30,000 restricted stock units, increasing his beneficial ownership to 364,262 shares.

Summary

• Glenn P. Muir, a Director of Neuronetics, Inc. (STIM), acquired 30,000 shares of common stock on May 22, 2025.
• This acquisition was in the form of a Restricted Stock Unit (RSU) award.
• Each RSU represents a contingent right to receive one share of Neuronetics' common stock.
• The RSU award vests on the earlier of May 22, 2026, or Mr. Muir's Board-approved separation of service from the Issuer, contingent on continuous service.
• Following this transaction, Mr. Muir directly beneficially owns 364,262 shares of Neuronetics common stock.

Sentiment

Score: 6

Explanation: The grant of RSUs to a director is a standard compensation practice, aligning insider interests with shareholders. It's a neutral to slightly positive event as it indicates continued commitment and incentivization, but does not reflect operational performance or significant strategic shifts.

Positives

• The grant of Restricted Stock Units (RSUs) to Director Glenn Muir aligns his interests with those of shareholders, as the value of the award is tied to the company's stock performance.
• An increase in beneficial ownership by a director can signal confidence in the company's future prospects.

Negatives

• No negative aspects were identified in this Form 4 filing, as it reports an acquisition of shares rather than a disposition.

Future Outlook

NA

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically an equity award to a director. Such awards are common practice across various industries, including medical technology, to incentivize and retain key personnel by aligning their financial interests with company performance.

Stakeholder Impact

• **Shareholders**: The RSU grant aligns the director's long-term interests with shareholder value creation, as the value of the award is tied to the company's stock performance.
• **Employees**: No direct impact on general employees is indicated by this filing.

Next Steps

• The Restricted Stock Units (RSUs) are expected to vest on May 22, 2026, or earlier upon Board-approved separation of service, subject to continuous service.

Key Dates

Recommendation

Keywords

Neuronetics, STIM, Form 4, SEC filing, insider transaction, restricted stock units, RSU, director compensation, beneficial ownership, equity award